This workshop provides a clear, practical framework for building credible investor-ready valuations. Through real-world examples and interactive exercises, you’ll walk away with tools you can immediately apply, including:
• The key startup valuation methods used across medtech, pharma and digital health
• How to build robust financial projections aligned with investor expectations
• Common valuation and projection pitfalls — and how to avoid them
• The signals investors look for during negotiation and due diligence
The session will conclude with a Q&A to address your specific challenges.
Don’t miss this opportunity to sharpen your fundraising strategy and strengthen your valuation expertise!
About the speaker
Pierre Corval is a Senior Manager at EY Geneva with over 20 years of experience advising clients on M&A and valuation topics. Prior to joining EY Geneva, Pierre worked in the firm’s Strategy and Transactions teams in Chicago and Denver, supporting life sciences companies across multiple stages of growth.
📗 Agenda:
• 11:45–12:30 Doors open + networking
• 12:40–14:00 Presentation
• 14:00–14:30 Networking
🚗 PARKING NOTICE: Please note that no parking spots are reserved for Café+Croissant's participants at Campus Biotech. However, paid parking is available nearby at Parking Sécheron, depending on availability. We encourage you to come to Campus Biotech by public transport (Tram 15, stop: Maison de la Paix).
